Ara
Toplam kayıt 11, listelenen: 11-11
Progress and challenges for the machine learning-based design of fit-for-purpose monoclonal antibodies
(TAYLOR & FRANCIS INC, 2022)
Although the therapeutic efficacy and commercial success of monoclonal antibodies (mAbs) are tremendous, the design and discovery of new candidates remain a time and cost-intensive endeavor. In this regard, progress in the ...